‹ All stocks
biote Corp.
BTMD · NASDAQ · Healthcare
$1.17
▼ $1.17 (-0.43%)
Day range
$1.10 – $1.18
Year range
$1.10 – $3.26
Open
$1.18
Previous close
—
Market cap
$51.61M
Volume (24h)
$24.6K
Volume (52w)
$28.80K
Performance
7D
▼ -4.88%
1M
▼ -22.52%
3M
▼ -48.00%
6M
▼ -20.41%
1Y
▼ -59.79%
YTD
▼ -52.63%
3Y
▼ -78.53%
5Y
▼ -88.02%
All-time
▼ -88.36%
Key statistics
P/E ratio
10.64
EPS (TTM)
$0.11
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
44.1M
About biote Corp.
Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1156.42 | 0.49% |
JNJ Johnson & Johnson |
$254.52 | -0.58% |
ABBV AbbVie |
$262.04 | 0.29% |
MRK Merck & Co. |
$139.70 | -2.76% |
UNH UnitedHealth Group Incorp… |
$371.61 | -0.19% |